Abstract-Accurately predicting the binding affinities of large diverse sets of protein-ligand complexes efficiently is a key challenge in computational biomolecular science, with applications in drug discovery, chemical biology, and structural biology. Since a scoring function (SF) is used to score, rank, and identify potential drug leads, the fidelity with which it predicts the affinity of a ligand candidate for a protein's binding site has a significant bearing on the accuracy of virtual screening. Despite intense efforts in developing conventional SFs, which are either force-field based, knowledge-based, or empirical, their limited predictive accuracy has been a major roadblock toward cost-effective drug discovery. Therefore, in this work, we explore a range of novel SFs employing different machine-learning (ML) approaches in conjunction with a variety of physicochemical and geometrical features characterizing protein-ligand complexes. We assess the scoring accuracies of these new ML SFs as well as those of conventional SFs in the context of the 2007 and 2010 PDBbind benchmark datasets on both diverse and protein-family-specific test sets. We also investigate the influence of the size of the training dataset and the type and number of features used on scoring accuracy. We find that the best performing ML SF has a Pearson correlation coefficient of 0.806 between predicted and measured binding affinities compared to 0.644 achieved by a state-of-the-art conventional SF. We also find that ML SFs benefit more than their conventional counterparts from increases in the number of features and the size of training dataset. In addition, they perform better on novel proteins that they were never trained on before.
INTRODUCTION
P ROTEIN-LIGAND binding affinity is the principal determinant of many vital processes, such as cellular signaling, gene regulation, metabolism, and immunity, that depend upon proteins binding to some substrate molecule [1] . Consequently, it has a central role in drug design, which involves two main steps: first, the enzyme, receptor, or other protein responsible for a disease of interest is identified; second, a small molecule or ligand is found or designed that will bind to the target protein, modulate its behavior, and provide therapeutic benefit to the patient. Typically, highthroughput screening (HTS) facilities with automated devices and robots are used to synthesize and screen ligands against a target protein. However, due to the large number of ligands that need to be screened, HTS is not fast and costeffective enough as a hit identification method in the initial phases of drug discovery [2] . Therefore, computational methods referred to as virtual screening are employed to complement HTS by narrowing down the number of ligands to be physically screened. In virtual screening, information such as structure and physicochemical properties of a ligand, protein, or both, are used to estimate binding affinity (or binding free energy), which represents the strength of association between the ligand and its receptor protein.
The most popular approach to predicting binding affinity (BA) in virtual screening is structure-based in which physicochemical interactions between a ligand and a receptor are deduced from the 3D structures of both molecules. This in silico method is also known as protein-based as opposed to the alternative approach, ligand-based, in which only ligands that are biochemically similar to the ones known to bind to the target are screened. Since ligand-based screening does not directly take information about the target into account, it may not be as effective in identifying novel chemicals as hits. Therefore, it is the method of choice when the 3D structure of the target is not available. With the unprecedented growth in the number of available 3D structures of protein-ligand complexes in the last decade, interest in the protein-based approach has increased. It is more accurate than the ligand-based approach due to the inclusion of shape and volume information extracted from the 3D structure of a protein during the screening process [3] , [4] .
In this work, our focus will be on protein-based drug design, wherein ligands are placed into the active site of the receptor. The 3D structure of a ligand, when bound to a protein, is known as ligand active conformation. Binding mode refers to the orientation of a ligand relative to the target and the protein-ligand conformation in the bound state. A binding pose is simply a candidate binding mode. In molecular docking, a large number of binding poses are evaluated using a scoring function (SF), which is a mathematical or predictive model that produces a score representing the binding free energy of a binding pose. The outcome of the docking run, therefore, is a set of ligands ranked according to their predicted binding scores. Typically, corporate databases contain thousands to millions of ligand candidates that can be screened using an SF. Alternatively, novel ligands can be designed from scratch (de novo design) based on the 3D structure of the binding pocket of the target protein and then assessed using an SF. SFs are also employed for lead optimization of screening hits for affinity and selectivity. Finally, top-ranked ligands, considered the most promising drug candidates, are synthesized and physically screened using HTS. Besides drug discovery, molecular docking has applications in the design of chemical probes to investigate the biochemical role of a target of interest [5] and in many structural bioinformatics problems, such as protein structure [6] and function prediction [7] . It has become attractive because of the ever-increasing number of available receptor protein structures and putative ligand drug candidates in publicly-accessible databases, such as the Protein Data Bank (PDB) [8] , Cambridge Structural Database (CSD) [9] , and other related databases [10] , [11] , [12] , and corporate repositories.
The most important steps in the docking process are scoring ligands' conformations at their respective binding sites and ranking ligands against each other. These core steps affect the outcome of the entire drug search campaign. That is because predictions of scoring functions determine which binding orientation/conformation is deemed the best, which ligand from a database is considered likely to be the most effective drug, and the estimated BA. Correspondingly, three main capabilities that a reliable scoring function should have are: (i) the ability to identify the correct binding mode of a ligand from among a set of (computationally-generated) poses, (ii) the ability to correctly rank a given set of ligands, with known binding modes when bound to the same protein, and, finally, (iii) the ability to produce binding scores that are (linearly) correlated to the experimentallydetermined BAs of protein-ligand complexes with known 3D structures. These three performance attributes were referred to by Cheng et al. as docking power, ranking power, and scoring power, respectively [13] . In this paper, we are concerned with the assessment of the scoring powers of SFs. In order to assess the intrinsic accuracies of SFs in a fair manner and consistent with accepted practice [13] , [14] , we isolate the scoring step from the docking process and focus on the accuracy of BA prediction using an SF of test complexes with known 3D structures given training complexes with known 3D structures and BA data. It should be noted that, apart from SFs, there are other computational approaches, such as those based on molecular dynamics or Monte Carlo simulations, to estimate BA; however, these methods are too compute intensive for high throughput applications in structure-based drug design [13] , and are therefore not considered in this paper.
Most SFs in use today can be categorized as either forcefield-based, empirical, or knowledge-based SFs. In force-field methods, the potential of a system is formulated by calculating physical atomic interactions between the protein and ligand that include van der Waals forces, bonding and nonbonding interactions, and electrostatic energies. Parameters that define these intermolecular interactions are derived from experimental data and ab initio simulations. Empirical SFs adopt a different philosophy for calculating the free energy of the system. The energy as a whole in this type of function is assumed to be composed of weighted energy terms. Each term describes a chemically intuitive interaction such as hydrogen bonding, desolvation effect, van der Waals interactions, hydrophobicity, and entropy. A fitting to a training dataset of known experimental binding energies is typically conducted to calibrate the coefficients of interest via linear regression [15] , [16] . Finally, knowledgebased scoring is founded on the theory that large databases of protein-ligand complexes can be statistically mined to deduce rules and models that are implicitly embedded in the data. Such models are then utilized to estimate binding energies of new protein-ligand complexes.
Despite intense efforts into such conventional scoring schemes, several recent studies report that the predictive power of existing SFs is quite limited. A recent extensive study by Plewczynksi et al. evaluated the performance of seven popular docking tools in finding native or near-native poses for 1,300 protein-ligand complexes [17] . They found that two docking programs, namely GOLD [18] and eHITS [19] , were able to successfully identify the correct poses for 60 percent of all complexes. Despite this reasonable docking accuracy, the SFs of all seven programs had very low scoring accuracies of no more than 0.38 in terms of Pearson correlation coefficient between predicted and in vitro BAs. Cheng et al. also recently conducted an extensive test of sixteen SFs employed in mainstream docking tools and researched in academia [13] . They analyzed the performance of each SF in terms of its ability to predict the BA of protein-ligand complexes whose high resolution structures and binding constants are experimentally known. The main test set used in this study consisted of a core set of 195 diverse protein-ligand complexes and four other proteinfamily-specific test sets in the 2007 version of PDBbind [10] . Considering different evaluation criteria and test datasets, they concluded that no single SF was superior to others in every aspect. In fact, the best SF in terms of predicting binding constants that are most correlated to the experimentally calculated ones was not even in the top five when the goal was to identify the correct binding pose of the ligand. These findings agree to some extent with an earlier study conducted by Wang et al. that considered very similar datasets and SFs [20] . In both of these studies, SFs examined were force-field-based, empirical, or knowledge-based.
Conventional SFs assume a predetermined functional form for the relationship between the features that characterize a protein-ligand complex and the predicted BA-the particular form being dependent on the type of SF and the nature of the intermolecular interaction being characterized and often involving parameters that are fitted to training data [14] . Previous conventional and machine-learning (ML) SFs use a minimal set of nonredundant and uncorrelated features to avoid overfitting. This functional form rigidity and feature parsimony limits their accuracy (e.g., because of inadequate modeling and characterization of polar interactions, solvation/desolvation energies, configurational entropy, and protein flexibility [13] , [21] ). Alternatively, nonparametric models can be employed so that the underlying unknown function can be inferred from the training data itself [14] . We seek to advance structure-based drug design by designing scoring functions that significantly improve upon the protein-ligand BA prediction accuracy of conventional SFs. We do so by coupling the modeling power of flexible non-parametric ML algorithms with training datasets comprising hundreds of protein-ligand complexes with known high-resolution 3D crystal structures and experimentally-determined BAs and a variety of features, possibly used in conventional SFs, characterizing the complexes. Various nonparametric machine-learning methods inspired from statistical learning theory are examined in this work to model the unknown function that maps structural and physicochemical information of a protein-ligand complex to a corresponding binding energy value. Some of our ML SFs are based on ensemble methods that are quite robust to overfitting even when a large number of, possibly correlated, features are used. This allows us to effectively exploit numerous, possibly correlated, and multiple types of features within the same ML method to improve prediction accuracy. Ours is the first work to perform a comprehensive assessment of the scoring accuracies of conventional and ML SFs across both diverse and homogeneous (protein-family-specific) benchmark test sets using a common diverse set of features across the ML SFs. We show that the best ML SF has a scoring power of 0.806 (in terms of Pearson correlation coefficient between predicted and experimentally-determined BAs) compared to 0.644 for the best conventional SF for the diverse core test set of the 2007 PDBbind benchmark-this is a significant improvement in predictive power.
Our work on ML SFs for protein-ligand BA prediction advances the limited previous work in this area as discussed next. Motivated by the functional form rigidity of conventional SFs like we are, Ballester and Mitchell recently proposed RF-Score [14] , [22] , which is an application of Breiman's Random Forests non-parametric ML technique [23] to geometrical features used previously to characterize complexes [24] , [25] . Theirs is the first work to demonstrate substantial improvement (scoring power of 0.777) obtained using a major ML technique (random forest) on a large standardized benchmark dataset (2007 PDBbind core set) compared to conventional SFs for the protein-ligand BA prediction problem. Our work differs from theirs in that we not only consider random forest, geometrical features, and the diverse core set of 2007 PDBbind like they do, but also a variety of other ML techniques, additional types of features (used in X-Score [16] and AffiScore [26] , [27] , [28] SFs), and the protein-family-specific test sets of 2007 PDBbind and the larger 2010 PDBbind dataset in our experiments. An important distinguishing aspect of our work is that we do not a priori limit an SF method to use only a single type of feature or to use a minimal set of nonredundant, uncorrelated features without making a determination as to whether it suffers from overfitting for the training, test, and feature sets under consideration. There are also significant differences in the experiments we conduct, e.g., in the various combinations of ML techniques and feature types we explore and the impact on BA prediction accuracy of various combinations of feature types and of limiting BLAST sequence similarity between binding sites of proteins in training and test complexes to assess the performance of ML SFs on novel targets. Prior to RF-Score, Deng et al. applied kernel partial least squares modeling to geometrical features characterizing complexes [25] and Amini et al. considered support vector regression [29] for protein-ligand BA prediction. Both of these studies showed promising results for ML methods, but considered small test sets. Our previous work comparing conventional and ML SFs includes a brief study reporting scoring power results on the 2007 PDBbind diverse core set and protein-family-specific test sets [30] considering only AffiScore features for the ML SFs, but not including any of the other experiments, features, and results reported in this paper, and another comprehensive study with experiments geared towards ranking power [31] , [32] rather than scoring power assessment as is the case with this work.
The remainder of the paper is organized as follows. Section 2 presents the compound database used for the comparative assessment of SFs (Section 2.1), the physicochemical features extracted to characterize the compounds (Section 2.2), the training and test datasets employed (Section 2.3), and the conventional (Section 2.4) and ML SFs (Section 2.5) we study. Next, in Section 3, we describe measures used to assess the performance of SFs (Section 3.1), present results comparing the scoring accuracies of conventional and ML SFs on diverse (Section 3.2) and homogeneous (Section 3.3) test sets. We also compare the performance of the ML techniques on novel drug targets (Section 3.4), and analyze how they are impacted by training set size (Section 3.5) and the type and number of features used to characterize different protein-ligand interactions (Section 3.6). Conclusions are in Section 4.
MATERIALS AND METHODS

Compound Database
We use the 2007 version of PDBbind [10] , the same complex database that Cheng et al. used as a benchmark in their recent comparative assessment of sixteen popular conventional SFs [13] . PDBbind is a selective compilation of the PDB database [8] . Both databases are publicly accessible and regularly updated. The PDB is periodically mined and only complexes that are suitable for drug discovery are filtered into the PDBbind database. In PDBbind, a number of filters are imposed to obtain high-quality protein-ligand complexes with both experimentally-determined BA and three-dimensional structure data from PDB [13] . First, only complexes that consist of only one protein and one valid ligand bound to it are considered. The validity of a ligand is determined by its molecular weight (which must not exceed 1000) and the number of its non-hydrogen atoms (which must be six or more). The BAs of these protein-ligand complexes are then assembled from the literature. The BAs considered are dissociation constant (K d ), inhibition constant (K i ), and concentration at 50 percent inhibition (IC 50 ). For these measurements to be accepted, they must be reported at normal room temperature and neutral pH values. Second, a high-quality subset of the complexes identified in the first step is compiled into a set referred to as the refined set. Each protein-ligand complex in the refined set must meet the following requirements: (i) it must have a stable experimental BA value such as K d or K i ; complexes for which only IC 50 values are known are excluded due to the measurement's dependence on binding assay conditions; (ii) only one ligand is bound to the protein; (iii) protein and ligand molecules must be non-covalently bound to each other; (iv) the resolution of the crystal structure of the complex does not exceed 2.5 Angstrom (A ); and (v) for compatibility with molecular modeling software, neither the residues in the protein binding pocket nor the ligand are allowed to have organic elements other than C, N, O, P, S, F, Cl, Br, I, and H. Finally, protonation of both molecules in complex structures is carried out using SYBYL tool [33] . Protonation and deprotonation of specific groups were performed for proteins and ligands under neutral pH.
The PDBbind curators compiled another set from the refined set. It is called the core set and is mainly intended to be used for benchmarking docking and scoring systems. The core set is composed of diverse protein families and diverse BAs. BLAST [34] was employed to cluster the refined set based on protein sequence similarity with a 90 percent cutoff. From each resultant cluster, three protein-ligand complexes were selected to be its representatives in the core set. A cluster must fulfill the following criteria to be admitted into the core set: (i) it has at least four members and (ii) the BA of the highest-affinity complex must be at least 100-fold of that of the complex with the lowest one. The representatives were then chosen based on their BA value: the complex with the highest affinity, the complex with the lowest affinity, and the complex with affinity close to the mean value for the cluster. The approach of constructing the core set guarantees unbiased, reliable, and biologically rich test set of complexes. In order to be consistent with the comparative framework used to assess the sixteen SFs mentioned above [13] , we too consider the 2007 version of PDBbind. This version has a 1300-complex refined set and a 195-complex core set (with 65 clusters). We also take advantage of the newlydeposited complexes in the 2010 version of the PDBbind database in some of our experiments-considering larger samples of data makes our conclusions regarding the performance of scoring functions in these experiments more statistically sound. The refined set of 2010 PDBbind has 2061 entries, of which the 2007 refined set is a subset except that a small portion of the latter is not included in the 2010 one due to some modifications in the filtering criteria.
Compound Characterization
Physicochemical and geometrical features used by the empirical SFs X-Score [16] and AffiScore [26] , [27] , [28] and the ML SF RF-Score [14] are extracted for all protein-ligand complexes available at our disposal. X-Score is implemented by Wang et al. as a standalone SF [16] , whereas AffiScore is part of the SLIDE docking tool and it supports standalone scoring mode as well [26] . In X-Score, the binding free energy for a given three-dimensional protein-ligand structure is estimated by summing six weighted energy terms. These terms include: (i) van der Waals interactions between the ligand and the protein; (ii) hydrogen bonding between the ligand and the protein; (iii) the deformation effect which is expressed as a contribution of the number of rotors (rotatable bonds) for the ligand (the protein contribution to this term is ignored); and (iv) the hydrophobic effect. The last term is computed in three different ways, which in turn leads to three different versions of X-Score SF. One version models the hydrophobic effect by counting pairwise hydrophobic contacts between the protein and the ligand. The second one computes this term by examining the fit of hydrophobic ligand atoms inside the hydrophobic binding site of the protein. The last SF version accounts for hydrophobicity by calculating the hydrophobic surface area of the ligand buried upon binding. We consider the three versions of the hydrophobic interaction as distinct features and accordingly we obtain a total of six X-Score descriptors for each protein-ligand complex.
SLIDE's SF, AffiScore, calculates the binding free energy in a similar fashion to X-Score. AffiScore is also an empirical SF whose energy terms include: (i) a term capturing hydrophobic complementarity between the protein and the ligand; (ii) a polar term, which is the sum of the number of proteinligand H-bonds, the number of protein-ligand salt-bridges, and the number of metal-ligand bonds; and (iii) the number of interfacial unsatisfied polar atoms. We did not limit ourselves to these terms only; we considered all 30 features that AffiScore calculates (listed in Section S1 of the supplementary material, which can be found on the Computer Society Digital Library at http://doi.ieeecomputersociety.org/ 10.1109//TCBB.2014.2351824). Most of these contribute to the three main terms AffiScore directly uses. The 30 features are not directly accounted for in the final AffiScore model. The reason is perhaps to prevent the model from overfitting. Several features are linear combinations of each other. This is in addition to a significant amount of redundancy among them. Our experiments suggest that such inter-correlation and redundancy among features is not a major hindrance for some of the ML models we consider.
The features used by X-Score and AffiScore are computed mathematically from the geometrical coordinates and chemical properties of protein-ligand atoms in 3D space. Usually, such terms have a clear biochemical interpretation. A simpler approach used by knowledge-based SFs, and recently in RF-Score, does not require deriving such complex terms. Instead, a straightforward algorithm outputs a number of terms, each of which represents the number of occurrences of a certain protein-ligand atom pair within a predefined distance. Atoms of nine chemical elements are considered, which translates to a total of (9 Â 9 ¼) 81 atom-pair frequencies. The nine common elements taken into account in protein and ligand molecules are C, N, O, F, P, S, Cl, Br, and I. As pointed out in [14] (and confirmed by our experiments), 45 of the resulting features have a zero value across all PDBbind compounds. Such terms were discarded and we only include the remaining 36 terms to achieve maximal data compactness. The distance cutoff we use here is 12 A . This value is recommended in [24] for being adequately large to implicitly capture solvation effects. A full list of XScore, AffiScore, and RF-Score features, as well as links to the tools that were used to extract them, is provided in Section S1 of the supplementary material, available online.
Training and Test Sets
We extracted features for the complexes in the core set of PDBbind 2007 and we stored them in a dataset referred to as the core test set which is denoted by Cr and includes 195 complexes. A primary training set was built by removing all Cr complexes from the 1,300 complexes in the refined set of the same year. As a result, the primary training set, or Pr for short, contains 1,105 complexes that are completely disjoint from Cr complexes. The refined sets of PDBbind 2007 and 2010 (2,061 complexes) were the source of another set that comprises 1,987 complexes. We refer to this set as the secondary training set, or Sc for short. The set Sc is composed of all the unique complexes in both 2007 and 2010 PDBbind releases after excluding all those in Cr, i.e., Sc = (2007 refined set) [ (2010 refined set)n(2007 core set). A summary of the training and test sets used in this paper is provided in Table  S2 of the supplementary material, available online.
For each protein-ligand complex, we extracted features using the X-Score (a set of six features denoted by X), AffiScore (a set of 30 features denoted by A), and RF-Score (a 36-feature set denoted by R) tools as discussed above. By considering all seven combinations of these three types of
we generated seven versions of the Pr, Sc, and Cr datasets, which we distinguish by using appropriate subscripts identifying the features used. For instance, Pr XR denotes the version of Pr comprising the set of features X [ R (referred to simply as XR) and experimentally-determined BA data for complexes in the Pr dataset. We note that the use of R features (extracted using the RF-Score tool) does not imply that only random forest based SF will be applied to such descriptors (although that is what was done in [14] ). In our work, we place no restriction on the type of ML SF that can be built using the R features.
Conventional Scoring Functions
A total of sixteen popular conventional SFs are compared to ML SFs in this study. The sixteen functions are either used in mainstream commercial docking tools and/or have been developed in academia. The functions were recently compared against each other in a study conducted by Cheng et al. [13] . This set includes five SFs in the Discovery Studio software version 2.0 [35] : LigScore, PLP, PMF, Jain, and LUDI. Five SFs in SYBYL software (version 7.2) [33] : DScore, PMF-Score, G-Score, ChemScore, and F-Score. GOLD software version 3.2 [18] contributes three SFs: GoldScore, ChemScore, and ASP. GlideScore [36] in Schr€ odinger software version 8.0 [37] . Besides, two standalone SFs developed in academia are also assessed, namely, DrugScore [38] and X-Score version 1.2 [16] .
Since molecular modeling software programs often provide multiple SF choices, we use notation, same as that employed by Cheng et al. [13] , to identify both the modeling program and the SF used. For example, when referring to the SF LigScore1 in Discovery Studio software, the notation DS:: LigScore1 is used. Considering all SFs possible from the modeling tools mentioned in this subsection would result in large numbers of them. That is because modeling tools typically supply more than one version/option for the same SF. Each such variation could be regarded as a different SF. LigScore, for example, comes in two different flavors (LigScore1 and LigScore2). For brevity, we only report the version and/ or option that yields the best performance on the PDBbind benchmark that was considered by Cheng et al. [13] .
Machine Learning Methods
We utilize a total of six regression techniques in our study: multiple linear regression (MLR), multivariate adaptive regression splines (MARS), k-nearest neighbors (kNN), support vector machines (SVM), random forests (RF), and boosted regression trees (BRT) [39] . In Section S2 of the supplementary material, available online, we provide a brief description of each ML method, the software packages implementing them, and the optimal parameters for each ML-method-feature-set combination we use in subsequent experiments.
After tuning their parameters, we applied the six ML methods to all seven combinations of the X, A, and R features (viz., X, A, R, XA, XR, AR, and XAR) for the datasets Pr, Sc, and Cr. Therefore, for each dataset, we considered (6 Â 7 ¼) 42 different SFs. We distinguish them using the notation ML technique::tools used to calculate features. For instance, kNN:: XA implies that the SF is a kNN model that is trained and tested on datasets (say, primary training set and the core set, respectively) described by XA features (i.e., features extracted using the X-Score and AffiScore tools). Again, as in the case of conventional SFs, for brevity, for each ML technique (unless otherwise noted) we report results only for the feature combination (out of the seven possible) that yields the best performance.
RESULTS AND DISCUSSION
In this section, we present results from experiments designed to assess the scoring power performance of various SFs.
Evaluation of Scoring Functions
Scoring power is measured using Pearson and Spearman correlation coefficients (denoted by R p and R s , respectively, and with values in the range À1; 1 ½ ) and, root-meansquare error (RMSE), in log K d or log K i units, between predicted and experimentally-determined BAs [20] . Higher values of R p and R s and lower values of RMSE imply higher scoring accuracy. Due to space constraints, only R p results are reported here; R s and RMSE results show similar trends and are provided in the supplementary material, available online, as noted in the captions of tables and figures of this section.
ML versus Conventional Approaches on a Diverse Test Set
In Table 1 , we report the scoring performance of seven ML (including RF-Score [14] ) and sixteen conventional SFs on the core test Cr comprising 65 three-complex clusters corresponding to diverse protein families. The ML SFs were trained on Pr and then used to predict BAs for the complexes in the core test Cr, while the results for the conventional SFs were calculated based on their predicted BA data for the core test from [13] . SFs are ordered based on their scoring power in terms of R p . We also report the scoring performance of ML SFs on the training set Pr by using 10-fold-cross validation to calculate how close the predicted BAs are to the experimentally-measured ones in terms of RMSE. Therefore, this statistic indicates whether SFs deemed accurate on training data will also be reliable scoring models on the test set Cr. It should be noted that such a boost in performance comes purely from the powerful fitting algorithm and the diversity of features describing protein-ligand complexes (since features used in both empirical and knowledge-based SFs are employed by the best ML approaches). There is also 4 percent improvement in performance over RF-Score when X-Score as well as geometrical features (XR) are used to build an RF-based SF instead of using geometrical features (R) only as in the case of RF-Score. SVM and kNN follow ensemble techniques RF and BRT in accuracy and they are also fitted to complexes characterized using a diverse set of features.
This is also the case for the relatively less accurate MARS and MLR models. For the ML SFs, we note that smaller RMSE values on Pr are generally associated with higher R p values on Cr, which signifies that ML SFs that fit the training data well are indeed likely to be the best performers on the test set as well.
ML versus Conventional Approaches on Homogeneous Test Sets
In the experiment described in Section 3.2, the performance of SFs was assessed on the diverse test set Cr. The core set consists of more than sixty different protein families that are related to a subset of protein families in Pr. That is, while the training and test set complexes were different (at least for all the ML SFs), proteins present in the core test set are also present in the training set, albeit bound to different ligands. A much more stringent test of SFs is their evaluation on a completely new protein, i.e., when test set complexes all feature a given protein-test set is homogeneous-and training set complexes do not feature that protein. To address this issue, four homogeneous test sets were used corresponding to the four most frequently occurring proteins: HIV protease (112 complexes), trypsin (73), carbonic anhydrase (44), and thrombin (38) [13] . Each of these protein-specific test sets was formed by extracting complexes containing the protein from Cr (one cluster or three complexes) and Pr (remaining complexes). For each test set, we retrained BRT, RF, SVM, kNN, MARS, and MLR models on the non-test-set complexes of Pr. The upper portion of Table 2 provides scoring performance statistics in terms of R p for the resulting ML SFs on the four protein-specific test sets. These ML SFs are also compared to the best performing four out of the conventional sixteen SFs. The predictive accuracy of all SFs is clearly dependent on the protein family under consideration. For HIV protease complexes, none of the SFs are able to achieve accuracy of more than 0.459 in R p value. This poor performance can perhaps be attributed to inaccurate accounting for enthalpic and entropic factors associated with HIV protease and ligand molecule binding which involves considerable conformational changes [13] . There is also possibly significantly lower sequence similarity between HIV protease and the proteins in the training set used (viz., Pr after HIV-protease-based complexes are removed). The performance of SFs on the remaining three test sets is better. Most SFs perform well on the trypsin test set, with R p values in the range 0.778-0.829. The empirical SF DS::PLP2 performs the best on the carbonic anhydrase dataset with an R p value of 0.800 and several others perform moderately but not nearly as well. The best performers in the thrombin test set are ML SFs with R p values of 0.700 and better, followed by several that perform only moderately well. In some of these test sets, a few conventional SFs perform better than ML SFs. As noted in the previous section, although training and test datasets were completely disjoint for ML models, that is not necessarily the case with the conventional SFs. When we repeat the experiment on the four homogeneous test sets, but this time using Pr as the training set (i.e., all test-set complexes, except the three from Cr, are part of the training set), ML SFs, particularly, BRT, SVM, RF, and kNN, excel 2 The measured BA and the BA prediction using ML SFs listed in this table of all core set complexes are provided in Table S6 of the supplementary material, available online. 3 SD is the standard deviation of errors between predicted and measured BA values of complexes in Cr based on Equation (3) in [20] . 4 RMSE on Pr. Training RMSE is not available for conventional SFs. 5 RMSE on Cr. Test RMSE is not available for conventional SFs. 6 Performance statistics for ensemble ML SFs are the average of 50 runs. Box plots and five-point summary of the 50 models are given in Fig. S1 and Table  S3 , respectively, of the supplementary material, available online. 7 The value of SD reported for RF-Score in [14] is 1.58. Our calculations yield a different value of 1.50 using Equation (3) in [20] . For consistency, we list the value we obtained.
in their scoring performance, as reported in the lower portion of Table 2 .
Results of the type reported in the upper portion of Table 2 , wherein the training set has no known binding ligands to the target protein under consideration, are useful when the goal is to assess the ability of SFs to accurately score ligands of novel protein targets. However, in practice, it has been observed that more than 92 percent of today's drug targets are similar to known proteins in the PDB [40] , an archive of high-quality complexes from which our training and test datasets originated. Therefore, if the goal of a screening campaign is to identify new ligands for a protein target or to optimize its leads, it is important to consider SFs calibrated with training sets containing some known binders to the protein target and assess their scoring ability on an independent test set of complexes that all feature the protein target, but bound to different ligands. To address this issue, we performed a separate experiment. Since HIV protease complexes are the most abundant in our dataset and they have proved to be the most challenging in the previous experiment (see the upper portion of Table 2 ), we focus on them. Also, we only consider ML SFs in this and subsequent experiments since, as noted earlier in Section 3.2, for the conventional 16 SFs we do not have access to their full training set BA values; in these cases, the MLR model, due its linear nature, can be considered representative of empirical SFs [15] , [16] .
The six ML SFs are trained using X, A, R, and XAR features on a training set that includes a randomly selected (without replacement) x percent of the 112 complexes (more precisely, bx Â 112=100c complexes) from the HIV protease homogeneous test set. The remaining complexes in the training set are the non-HIV-protease complexes in Pr, except that as many of them as the number of the added HIV complexes are randomly excluded from the training set. This means that the size of the training set is fixed and equals the number of non-HIV-protease complexes in Pr. Another different 20 percent of the 112 HIV protease complexes (more precisely, d0:2 Â 112e ¼ 23 complexes) are randomly selected (without replacement) to form the test set. This process is repeated 1000 times to obtain a robust average R p scoring measure for various values (0; 5; 10; . . . ; 80) of x (i.e., the percentage of HIV protease complexes) for the six ML models-these are plotted in Fig. 1 .
The performance behavior of ML SFs seems similar across the four feature sets as shown in panels (a) through (d) of Fig. 1 . There are three other important observations that can be made from these four panels. First, when the training dataset includes none to very few HIV protease complexes (roughly up to 5-10 percent of the total), the simpler linear model MLR ties with or outperforms some of the more sophisticated nonlinear techniques such as SVM, kNN, BRT, MARS, and RF. This is somewhat similar to that seen earlier in the upper portion of Table 2 . Second, the RF model clearly performs the best across the entire range of number of HIV complexes in training data characterized with XAR features. Other ML SFs such as kNN, SVM, and BRT also show substantial improvement in performance when trained on larger numbers of HIV complexes. Finally, MLR, due to its rigid linear nature that resembles that of empirical SFs, is not able to effectively exploit increasing numbers of HIV complexes in training data to improve its scoring accuracy in contrast to the other flexible models which show moderate (MARS) to significant improvement (kNN, RF, BRT, and SVM). For instance, for the XAR feature set (see Fig. 1d ), the scoring accuracy of some ensemble models improves by more than 90 percent (RF) or 140 percent (BRT) when the number of HIV complexes increases from 0 to 80 percent, whereas the corresponding increase in performance for the linear model does not even exceed 11 percent. A similar trend can also be observed for the other three feature sets in the other panels.
The analysis of the effectiveness of different regression approaches on specific families of proteins has very practical benefits in virtual screening and drug discovery. Typically, the task in drug design is to conduct computational screening of large numbers of ligands against a certain protein family. The knowledge of the number of known binders to that protein present in the training set and the characteristic plots of several scoring models (similar to the ones in Fig. 1 ) can aid in the selection of the most effective SF.
Performance of ML SFs on Novel Targets
The training-test set pair (Pr, Cr) (or similarly (Sc, Cr)) is a useful benchmark when the aim is to evaluate the performance of SFs on targets that have some degree of sequence similarity with at least one protein present in the complexes of the training set. This is typically the case since, as it was mentioned earlier, 92 percent of drug targets are similar to known proteins [40] . When the goal is to assess SFs in the context of novel protein targets, however, the training-test set pair (Pr, Cr) is not that suitable because of the partial overlap in protein families between Pr and Cr. We considered this issue to some extent in Section 3.3, where we investigated the performance of SFs on four different proteinspecific test sets after training them on complexes that did not have the protein under consideration. This resulted in a drop in performance of all SFs, especially, in the case of HIV protease as a target. However, even if there are no common proteins between training and test set complexes, different proteins at their binding sites may have sequence and structural similarities, which influence protein-ligand BA.
To more rigorously and systematically assess the performance of ML SFs on novel targets, we performed a separate set of experiments in which we limited BLAST sequence similarity between the binding sites of proteins present in the training and test set complexes. Sequence similarity was used to construct the core test set and it was also noted by Ballester and Mitchell as being relevant to testing the efficacy of SFs on a novel target [22] . Specifically, for each similarity cut-off value S = 30%, 40%, 50%, ..., 100%, we constructed 100 different independent 150-complex test and T-complex training set pairs, trained the scoring models (MLR, MARS, kNN, SVM, BRT, and RF) using two different feature sets (XAR and X features) on the training set and evaluated them on the corresponding test set, and determined their average performance over the 100 rounds to obtain robust results. Since SF prediction performance depends upon both similarity cut-off and training set size and since training set size is constrained by similarity cut-off (a larger S means a larger feasible T), we investigated different ranges of S (30 to 100 percent, 50 to 100 percent, and 70 to 100 percent) and for each range we set T close to the largest feasible value for the smallest S value in that range. Each test and training set pair was constructed as follows. We randomly sampled a test set of 150 protein-ligand complexes without replacement from all complexes at our disposal: 1987 in Sc + 195 in Cr = 2,182 complexes. The remaining 2,032 complexes were randomly scanned until T different complexes were found that had protein binding site similarity of S percent or less with the protein binding sites of all complexes in the test set-if less than T such complexes were found, then the process was repeated with a new 150-complex test set.
The accuracy of the six scoring models in terms of Pearson correlation coefficient R p is depicted in Fig. 2 for a variety of similarity cut-offs and training set sizes. The plots in the first column (Figs. 2a and 2d ) are for similarity cut-offs 30 to 100 percent in which T = 120 complexes is the largest training set size feasible for S = 30%. The upper plot (Fig. 2a) shows these results when protein-ligand complexes are described by XAR features and the bottom plot when such compounds are characterized by X-Score (X) features alone. When XAR features are used, RF and kNN perform the best across the entire range of S when T = 120. In the corresponding bottom plot, in which the six X features are considered, it can be easily observed that MLR, kNN, RF, and BRT are the top four performing models. In both feature set cases, we see that no ML SF is able to predict the measured BA with good accuracy (R p 0.5 when S = 30%). This can be attributed to three factors. First is the significant sequence, and hence structural, dissimilarity between the binding sites of proteins in training and test complexes. Second is the limited size of the training data. We will show how important the size of training data is in influencing the quality of scoring models in Section 3.5. Finally, the scoring model parameters used for this experiment were based on parameter tuning with respect to Pr as described in Section 2.5 rather than with respect to the training set used for this experiment, which is not only small but has a different mix of complexes governed by the small similarity cut-off of 30 percent. This is evident in Fig. 2a from the inferior performance of several SFs (MLR, SVM, MARS and, to a limited extent, BRT) when XAR features are used instead of X features (which is a subset of XAR features), signifying overfitting or suboptimal parameter values. The reason the RF model had relatively good performance compared to the other generally-competitive ML models for both XAR and X features is most likely because it is immune to overfitting and less sensitive to parameter tuning. Due to the time-intensive nature of tuning parameters of multiple scoring models for the many training scenarios we consider in this work, we used the parameters tuned with respect to Pr.
For a given similarity cut-off, not only does the scoring performance of models improve with the size of training dataset, the overfitting/parameter-tuning problem also gets alleviated or minimized. For example, for a similarity cut-off of 50 percent, BRT::XAR has inferior performance relative to BRT:X when training dataset has 120 complexes (0.46 versus 0.49), but the opposite is true when the training set has 520 complexes (0.54 versus 0.51). Also, the performance of RF and the other generally-competitive ML models (BRT and kNN) becomes comparable as training dataset size increases, signifying that parameter tuning becomes less of an issue.
To summarize, imposing a sequence similarity cut-off between the binding sites of proteins in training and test set complexes has an expected adverse impact on the accuracy of all scoring models. However, increasing the number of training complexes helps improve accuracy for all similarity cut-offs. RF has the best accuracy considering the entire range of similarity cut-offs. The other generally-competitive ML models (BRT, kNN, and SVM) may also provide comparable accuracy if parameter tuning is performed with respect to the training set being considered.
Impact of Training Set Size
Experimental information about 3D structure and BA of new protein-ligand complexes is regularly determined. This contributes to the growing size of public biochemical repositories and corporate compound banks. Training RFScore with an increasing number of protein-ligand complexes was shown in [14] to improve its accuracy in the context of the 2007 PDBbind dataset. To assess the impact that a larger training set size would have on the predictive accuracy of ML SFs, we consider the 2010 PDBbind dataset-more than 750 new protein-ligand complexes have been deposited into this database from the year 2007 to 2010. To be able to use a greater range of training set sizes, we choose the larger dataset Sc to build and test different ML scoring models. For a given number of training complexes x, x ¼ 1 Â 178; 2Â 178; . . . ; 10 Â 178, we select x complexes randomly (without replacement) from Sc to train the six ML models. We then test them on the disjoint core set Cr and a random test set comprising 150 complexes that are randomly drawn from Sc without any overlap with the x training complexes. This process is repeated 100 times to obtain robust average R p values, which are plotted in Fig. 3 .
The top two panels in Fig. 3 show the results when the datasets are characterized using XAR features, while the plots in the bottom panels are for the case when complexes are described by X features. In the four cases (two test sets and two characterization methods), we observe that the performance of almost all models improves as the size of the training dataset increases. When the number of features is high (jXARj = 72) and the size of training dataset is relatively small, we notice poor accuracy of some SFs such as MLR and SVM. This is perhaps a consequence of overfitting since the ratio of training dataset size to number of features is small. The performance of MLR and SVM improves substantially when the training dataset size increases and/or lower dimensional data is used (as shown in panels (c) and (d)). RF and BRT based SFs are almost always the leading models regardless of the data dimensionality and the size of training set.
It is evident that the scoring power of ML models is greater when the test is conducted on the core set compared to that on the random test set. It may be thought that testing SFs on randomly drawn instances should yield results similar to those obtained on the diverse test set Cr. Comparing curves in the left panels to the ones in the right shows that all SFs perform better on the core set. This gap in performance can be attributed to the large variance in binding energies of protein-ligand complexes constituting the core test set. Recall that while building the core set the emphasis was on diversifying it in terms of protein families and maximizing the range of their binding constants. It is therefore easier for SFs to estimate binding constants of very different proteinligand structures whose binding constants are far apart. Such variation is not guaranteed in case of randomly drawn protein-ligand complexes and hence their binding constants are rather less distinctive. Additionally, the way the core set is constructed, there is at least one complex in Pr (and therefore Sc as well) for each cluster represented in Cr. This implies that Sc has training complexes relevant to the complexes in Cr.
From Fig. 3 , we can conclude that most ML SFs have a potential for improvement as more training data becomes available. That is the case whether the ratio of training dataset size to the number of dimensions is low (178/72 = 2.47 to 1780/72 = 24.72 in Figs. 3a and 3b ) or relatively high (178/6 = 29.67 to 1780/6 = 296.67 in Figs. 3c and 3d ). SF designers can conduct similar experiments to estimate accuracy enhancement when their proposed functions are recalibrated on larger number of data instances. Take, for example, the RF model. We can approximately project its scoring power on the core test set after a few years from now. If we averaged its improvement slope over the last three increments in training size, we obtain roughly 0.01 increase in correlation for each 178 increase in number of training records. By assuming that another 1780 protein-ligand complexes will be deposited into PDBbind in the next few years, one can then optimistically expect (because of diminishing returns with increasing training dataset size) the scoring power of RF::XR on the test set Cr to go up to about R p = 0.906 (from the current R p = 0.806, i.e., over 12 percent increase) in the near future. This enhancement would certainly have a great impact when the goal is to only choose promising drugs from databases that contain millions of drug-like molecules.
MLR::X model, which resembles empirical SFs, has a very small potential for improvement in the future (see Figs. 3c  and 3d ). This is due to the rigidity of linear models whose performance tends to saturate. Many of the 16 conventional SFs considered in this study are empirical and thus they are also most likely to suffer from the same limitation. In fact, the best performing model of those 16 in terms of scoring power, X-Score::HMScore, is very similar to MLR::X. That is because both SFs use almost the same features and both are linearly fit to the same training data. Therefore, one should consider better prediction approaches to derive accurate models from training data available on hand and from future updates.
Impact of the Type and Number of Features
The BA of a protein-ligand complex depends on many physicochemical interaction factors that are too complex to be accurately captured by any one approach. Therefore, we perform two different experiments to investigate how utilizing different types of features from different scoring tools, X-Score, AffiScore, and RF-Score, and considering an increasing number of features affects the performance of the various ML models. In the first experiment, the ML models were trained on Pr characterized by X, A, R, XA, XR, AR, and XAR features and tested on the corresponding core test Cr characterized by the same features. Table 3 reports the R p performance statistic for the resulting 42 SFs.
We notice that the R p value of all models, except MARS and MLR, improves by considering more than one type of feature rather than just X, A, or R features alone. The results of Table 3 are useful in assessing the relative benefit of different types of features for the various ML models.
A pertinent issue when considering a variety of features is how well different SF models exploit an increasing number of features. The features we consider are the X, A, and a larger set of geometrical features than the R feature set available from the RF-Score tool. Recall from Section 2. ]. This provides us 6 X, 30 A, and (36 Â 5 ¼) 180 geometrical features or a total of 216 features. We randomly select (without replacement) x features from this pool, where x ¼ 20; 40; 60; . . . ; 200, and use them to characterize the Sc dataset, which we then use to train the six ML models. These models are subsequently tested on the Cr dataset characterized by the same features. This process is repeated 100 times to obtain robust average R p statistics, which are plotted in Fig. 4 . It should be noted that we used the values listed in Table S1 of the supplementary material, available online, for the meta-parameters to fit ML models in this experiment. The only exception is the mtry parameter of RF which is set to a third of the number of features (i.e., bx=3c) [23] .
Clearly, the various SFs have very different responses to an increase in the number of features. For several of them, peak performance is attained at 60 (kNN and MLR) or 120 (SVM) features and then there generally tends to be a drop in or saturation in performance at larger number of features. Although the features we used are distinct, they have varying degrees of correlation between them. This combined with larger number of features lead to overfitting problems for some of the SFs. Scoring performance is also provided in terms of R s and RMSE in Table S5 of the supplementary material, available online.
Further, ML model meta-parameters are not tuned for every number of features chosen. This especially affects the performance of SVM which we have found to be very sensitive to its parameter values. However, tuning SVM parameters for every number of features is computationally intensive, and therefore we did not attempt to search for the optimal parameter values for every feature set size for it. In contrast to these models, the performance of RF and BRT benefits from increasing number of features. Based on these results, utilizing as many relevant features as possible in conjunction with ensemble based approaches like BRT and RF that are resilient to overfitting is the best option. In related work, in Appendix A5 of [14] , it was found that considering all 36 R-type features in RF provided better performance than just considering the nine features corresponding to the most common heavy atoms C, N, and O.
CONCLUSION
In this paper, we considered the problem of scoring ligands based on how tightly they bind to their receptor proteins and comprehensively assessed 16 conventional and six ML SFs in various test scenarios. As in previous work, we found that there is no single scoring function that consistently outperforms others in all scoring aspects. However, we found that RF and BRT, which are SFs based on ensemble prediction, surpass others in prediction accuracy, with the best or near-best performance in most scoring scenarios. On the diverse core test set, using the best ML SF as opposed to the best conventional SF, scoring performance in terms of Pearson correlation coefficient between predicted and experimentally-determined BAs improved from 0.644 to 0.806. On the homogeneous test sets, ML models were better than or competitive with the top conventional approaches. The homogeneous HIV protease dataset proved to be challenging for all scoring models. However, we found that as the number of HIV protease complexes is increased in the training set, the performance of most ML models steadily improves. Empirical SFs with a small number of features or an RF-based SF may be used when the target is a protein not present in the training dataset used to build the scoring model. We also observed steady gains in the performance of ML SFs, in particular for those based on RF and BRT, as the training set size and type and number of features were increased. SFs based on MLR, which resemble empirical models, were not as effective at exploiting a larger training set size due to their rigidity. As a result of their susceptibility to overfitting, MLR SFs, and to some extent those based on MARS and SVM, degraded in performance as the number of features was increased. Overall, based on our results, we expect continued growth in prediction accuracy of ML SFs, especially RF-and BRT-based, as the number of known binders to the target protein, training set size, and type and number of features used increase in the future.
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